KALA

KALA, an innovative pharmaceutical compound, exhibits remarkable efficacy in addressing the intricate pathophysiological mechanisms underlying dry eye disease. By intricately and precisely modulating ocular lubrication and suppressing the deleterious effects of inflammation, this prodigious therapeutic intervention aptly ameliorates the enduring affliction experienced by patients ensnared in the torment of protracted desiccation, itching, and profound discomfort.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	GR2161
CAS	187987-64-0
M.F/Formula	C144H248N40O35S
M.W/Mr.	3131.82
Appearance	Solid

CAT#	Product Name	Inquiry
GR2190	TAT-DEF-Elk-1 TFA	Inquiry
GR2136	HN-1	Inquiry
GR2233	NGR peptide	Inquiry
GR2143	Angiopep-2 hydrochloride	Inquiry
GR2202	Anti-BetaGamma	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.